Annexin V antibodies in multiple sclerosis and SLE/APS
Author:
Baleva Marta1, Stoilova Detelina2, Shotekov Petko2, Nikolov Krasimir1
Affiliation:
1. 1Department of Clinical Immunology, University Hospital Alexandrovska, 1.G. Sofiiski Str., Sofia, 1431, Bulgaria 2. 2Clinic of Neurology, University Hospital “St Ivan Rilski”, Sofia, Bulgaria
Abstract
AbstractMultiple sclerosis (MS) is an autoimmune disease with unclear etiopathogenesis. Some MS patients have anticardiolipin (ACL), anti-beta-2-glycoprotein-I (B2GPI) and anti-annexin V (AnV) antibodies. These antibodies can also be found in systemic lupus erythematosus with antiphospholipid syndrome (SLE/APS). The aim of our study was to compare the levels of ACL, B2GPI and AnV antibodies in MS and SLE/APS. Materials and methods: We investigated serum levels of IgG and IgM ACL, B2GPI and AnV in 21 MS patients, 30 SLE/APS patients and 30 controls using ELISA. Results: Mean levels of IgM and IgG ACL and B2GPI in MS were comparable with controls and lower than SLE/APS (p<0.05). Mean levels of IgM AnV in MS were higher compared to SLE/APS and controls (p<0.05); mean levels of IgG AnV in MS were higher than normal but similar to SLE/APS (p>0.05). Discussion: The results show that MS with negative “classic” autoantibodies (ACL and B2GPI) and without clinical data for antiphospholipid syndrome may have other positive antiphospholipid antibodies, such as AnV. Larger studies are needed to clarify whether AnV are epiphenomenon of the vascular and organ damage or they play a pathogenic role in the development of MS.
Publisher
Walter de Gruyter GmbH
Reference32 articles.
1. Kaburaki J., Kuwana M., Yamamoto M., Kawai Sh., Ikeda Y., Clinical significance of anti annexin V antibodies in patients with systemic lupus erythematosus, Am. J. Hematol., 1997, 54, 209–213 2. Matsuda J., Saitoch N., Gohchi K., Gotoh M., Tsukamoto M., Anti annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody, Am. J. Hematol., 1994, 47, 56–58 3. Satoh A., Suzuki K., Takayama E., Kojima K., Hidaka T., Kawakani M., et al., Detection of anti — annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus, J. Rheumatol., 1999, 26, 1715–1720 4. Dubois T., Bisagni-Faure A., Coste J., Mavoungou E., Mankes C.J., Russo-Marie F., et al., High levels of antibodies to annexin V and VI in patients with rheumatoid arthritis. J. Rheumatol., 1995, 22, 1230–1234 5. Rodrigues-Garcia M.J., Fernandez J.A., Rodriguez A., Fernandez M.P., Gutierez C., Torre-Alonso J.C., Annexin V autoantibodies in patients with rheumatoid arthritis, Ann. Rheum. Dis., 1996, 55, 895–900
|
|